Neurogene: Interesting CNS Disease Company, Data Coming Soon
Neurogene has a $903M market cap with two phase 1/2 assets, NGN-401 for Rett Syndrome and NGN-101 for CLN5 Batten Disease.
This simple Google Search could infect your computer with dangerous malware
Are Bengal Cats legal in Australia?’—to trap unsuspecting internet users with data-stealing malware! A cybersecurity company ...
Arms senior VP explains AI's true impact, and its not what you think
Partly in light of three new Arm Cortex CPUs launching at Computex in June, Chris Bergey, Arm Senior Vice President and ...
J.P. Morgan Remains a Buy on Rocket Pharmaceuticals (RCKT)
J.P. Morgan analyst Eric Joseph maintained a Buy rating on Rocket Pharmaceuticals (RCKT – Research Report) yesterday and set a price ...
Amneal Pharmaceuticals, Inc. (NYSE:AMRX) Q3 2024 Earnings Call Transcript
Q3 2024 Earnings Call Transcript November 8, 2024 Amneal Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is ...
The Trade Desk, Inc. (NASDAQ:TTD) Q3 2024 Earnings Call Transcript
Q3 2024 Earnings Call Transcript November 7, 2024 The Trade Desk, Inc. beats earnings expectations. Reported EPS is $0.41, expectations were $0.3949. Operator: Greetings. Welcome to The Trade Desk ...